GLP-2 T (Tirzepatide)
Dual-receptor incretin class agonist studied in metabolic-pathway research.
GLP-2 T is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.
Its published Certificate of Analysis (lot 00011/0011, analyzed September 3, 2026) is from AV Analytics, a third-party laboratory, and reports 99.77% purity by HPLC; every published lot is listed on the product's COA page. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware), with storage notes on the lot's certificate.
GLP-2 T (Tirzepatide) is the catalog designation for a synthetic analog in the dual-agonist incretin class — compounds engineered to activate both the GIP and GLP-1 receptors from a single molecule. The dual-receptor approach emerged from the observation that the two incretin pathways interact synergistically in glucose regulation and energy balance.
Research interest centers on how simultaneous receptor engagement changes downstream signaling compared with single-receptor agonism: insulin secretion dynamics, adipose tissue effects, and hypothalamic feeding circuits all respond differently to the dual profile. The class generated some of the most cited metabolic research of recent years.
As with all coded incretin-class compounds in this catalog, GLP-2 T ships lyophilized with full HPLC documentation, for laboratory research use only.
Published research
Further reading in the lab library
Researchers also ordered
- AMY-ALong-acting amylin analog class agonist studied alongside incretin-receptor agonists in metabolic-pathway research.
- GLP-1 SSingle-receptor incretin class agonist studied in incretin-pathway metabolic research.
- GLP-3 R (Retatrutide)Triple-receptor incretin class agonist studied in metabolic-pathway research.